Metoclopramide Baxter

Metoclopramide, the active ingredient in Metoclopramide Baxter, is a dopamine antagonist presented as an injectable solution for intramuscular and intravenous use. It is employed to relieve nausea and vomiting, to improve gastric emptying, and to prevent postoperative and chemotherapy‑induced nausea in adult patients.

GNH USA supplies Metoclopramide Baxter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide is used across several gastrointestinal and emetic pathways to control nausea and improve motility. - Nausea and vomiting: reduces frequency and severity of acute and chronic episodes. - Postoperative nausea and vomiting: prevents and treats nausea after surgical procedures. - Chemotherapy‑induced nausea and vomiting: mitigates emesis associated with cytotoxic agents. - Gastroparesis: enhances gastric emptying and alleviates related symptoms.

Metoclopramide may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Drowsiness: feeling unusually sleepy or fatigued. - Restlessness: a sense of inner tension or inability to stay still. - Diarrhea: loose or frequent stools. - Fatigue: general lack of energy.

Serious or Rare Side Effects: - Extrapyramidal symptoms: involuntary muscle movements or rigidity. - Tardive dyskinesia: persistent, irreversible facial or tongue movements. - Neuroleptic malignant syndrome: life‑threatening fever, muscle rigidity, and autonomic instability.

Before initiating therapy, clinicians should consider several safety measures. - Assess renal and hepatic function: adjust use if impairment is present. - Monitor for extrapyramidal symptoms: watch for muscle rigidity or tremor. - Avoid in patients with known hypersensitivity to metoclopramide. - Use caution in the elderly: increased susceptibility to side effects. - Do not combine with other dopamine antagonists unless medically justified. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Metoclopramide can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Antipsychotics (e.g., haloperidol): additive dopamine blockade may increase extrapyramidal risk. - MAO inhibitors: heightened risk of hypertensive crisis. - CNS depressants (e.g., benzodiazepines): may potentiate sedation.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine): may raise metoclopramide plasma levels. - Serotonergic agents (e.g., ondansetron): monitor for serotonin syndrome signs.